Trending
- How Academic/Community Oncologists Improve Access to New Myeloma Therapies
- BRCA1/2 variant profiling and HPV/HMTV DNA detection in a cohort of Egyptian women with breast cancer
- Defining the Role of Neoadjuvant Radiation in Cholangiocarcinoma
- Managing Sustained MRD Negativity After Multiple Myeloma Therapy Ends
- PERSEUS Trial Shows Daratumumab Regimen Deepens Responses in NDMM
- Etentamig Shows Superior Efficacy vs SOC in Relapsed/Refractory Myeloma
- A major risk of breast cancer screening may have been overestimated for decades
- Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study
Saturday, September 26